HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 41 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $21,000 | -67.7% | 63,664 | -30.8% | 0.00% | – |
Q4 2019 | $65,000 | +3.2% | 92,064 | 0.0% | 0.00% | – |
Q3 2019 | $63,000 | -61.6% | 92,064 | -6.9% | 0.00% | – |
Q2 2019 | $164,000 | -33.1% | 98,864 | +0.7% | 0.00% | – |
Q1 2019 | $245,000 | +2.9% | 98,164 | +4.9% | 0.00% | – |
Q4 2018 | $238,000 | -49.1% | 93,564 | +0.9% | 0.00% | -100.0% |
Q3 2018 | $468,000 | +61.4% | 92,764 | +4.2% | 0.00% | – |
Q2 2018 | $290,000 | -8.8% | 89,064 | +1.4% | 0.00% | – |
Q1 2018 | $318,000 | – | 87,864 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonora Investment Management, LLC | 466 | $2,000 | 0.00% |